ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Janssen to Discontinue Pimodivir Influenza Development Program
September 04, 2020The Janssen Pharmaceutical Companies of Johnson & Johnson has made a strategic decision to discontinue the development of pimodivir, an investigational antiviral treatment for influenza A infection. -
New vaccine provides universal protection against influenza A, study finds
January 25, 2018Research led by Georgia State University has enabled the development of a universal vaccine for influenza A viruses, proven to provide long-lasting immunity in mice.
Pharma Sources Insight January 2025
